SYBX Synlogic Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SYBX

Price (delayed)

$1.84

Market cap

$21.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.81

Enterprise value

$13.65M

Synlogic™ is bringing the transformative potential of synthetic biology to medicine. With a premiere synthetic biology platform that leverages a reproducible, modular approach to microbial engineering, Synlogic designs Synthetic Biotic ...

Highlights
The gross profit has soared by 186% YoY
The revenue has soared by 186% YoY
SYBX's quick ratio has plunged by 63% YoY and by 37% from the previous quarter
The equity has declined by 48% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.synlogictx.com
Peers: OMER OMGA

Key stats

What are the main financial stats of SYBX
Market
Shares outstanding
11.65M
Market cap
$21.43M
Enterprise value
$13.65M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.4
Price to sales (P/S)
3.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.05
Earnings
Revenue
$3.37M
EBIT
-$57.27M
EBITDA
-$51.97M
Free cash flow
-$51.81M
Per share
EPS
-$8.81
Free cash flow per share
-$7.97
Book value per share
$4.64
Revenue per share
$0.52
TBVPS
$11.62
Balance sheet
Total assets
$75.55M
Total liabilities
$32.9M
Debt
$17.28M
Equity
$42.66M
Working capital
$29.5M
Liquidity
Debt to equity
0.4
Current ratio
2.45
Quick ratio
2.39
Net debt/EBITDA
0.15
Margins
EBITDA margin
-1,541.7%
Gross margin
100%
Net margin
-1,699.3%
Operating margin
-1,636.3%
Efficiency
Return on assets
-72.8%
Return on equity
-109.3%
Return on invested capital
-106.6%
Return on capital employed
-103.8%
Return on sales
-1,698.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SYBX stock price

How has the Synlogic stock price performed over time
Intraday
-1.08%
1 week
-2.13%
1 month
2.79%
1 year
-77.24%
YTD
-52.21%
QTD
2.79%

Financial performance

How have Synlogic's revenue and profit performed over time
Revenue
$3.37M
Gross profit
$3.37M
Operating income
-$55.16M
Net income
-$57.28M
Gross margin
100%
Net margin
-1,699.3%
The gross profit has soared by 186% YoY
The revenue has soared by 186% YoY
The operating margin has soared by 81% since the previous quarter and by 71% year-on-year
The company's net margin has surged by 80% QoQ and by 70% YoY

Growth

What is Synlogic's growth rate over time

Valuation

What is Synlogic stock price valuation
P/E
N/A
P/B
0.4
P/S
3.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.05
SYBX's EPS is up by 36% year-on-year and by 31% since the previous quarter
The P/B is 50% below the 5-year quarterly average of 0.8 and 33% below the last 4 quarters average of 0.6
The equity has declined by 48% year-on-year
The revenue has soared by 186% YoY
SYBX's P/S is 97% below its 5-year quarterly average of 112.7 and 85% below its last 4 quarters average of 24.0

Efficiency

How efficient is Synlogic business performance
SYBX's ROIC has plunged by 100% YoY and by 21% from the previous quarter
SYBX's return on sales has surged by 80% since the previous quarter and by 70% year-on-year
Synlogic's ROE has plunged by 79% YoY and by 15% from the previous quarter
The ROA has contracted by 49% YoY and by 7% from the previous quarter

Dividends

What is SYBX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SYBX.

Financial health

How did Synlogic financials performed over time
SYBX's total assets is 130% greater than its total liabilities
The current ratio has plunged by 63% YoY and by 41% from the previous quarter
SYBX's quick ratio has plunged by 63% YoY and by 37% from the previous quarter
The company's debt is 60% lower than its equity
The debt to equity has soared by 60% YoY but it has decreased by 4.8% from the previous quarter
The equity has declined by 48% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.